Evidence map›Paper›PMID 38791022›Full record

ArticleBiomedicines2024

Novel

Andrea Frustaci, Alessandro De Luca, Romina Verardo, Valentina Guida, Maria Alfarano, Camilla Calvieri, Luigi Sansone, Matteo Antonio Russo, Cristina Chimenti

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrea FrustaciIRCCS L. Spallanzani, Cellular and Molecular Cardiology Laboratory, 00149 Rome, Italy.ORCID 0000-0002-5748-0725
Alessandro De LucaIRCSS Fondazione Casa Sollievo della Sofferenza, Medical Genetics Division, 71013 San Giovanni Rotondo, Italy.ORCID 0000-0002-4408-8062
Romina VerardoIRCCS L. Spallanzani, Cellular and Molecular Cardiology Laboratory, 00149 Rome, Italy.
Valentina GuidaIRCSS Fondazione Casa Sollievo della Sofferenza, Medical Genetics Division, 71013 San Giovanni Rotondo, Italy.ORCID 0000-0003-3946-645X
Maria AlfaranoDepartment of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Camilla CalvieriDepartment of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-6548-3400
Luigi SansoneIRCCS San Raffaele, 00166 Rome, Italy.ORCID 0000-0003-3150-6461
Matteo Antonio RussoIRCCS San Raffaele, 00166 Rome, Italy.ORCID 0000-0002-5847-6015
Cristina ChimentiDepartment of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, Sapienza University of Rome, 00185 Rome, Italy.

Funding

The study has been supported by Ricerca corrente IRCCS L Spallanzani, and partially by Italian Health Ministry (IRCCS San Raffaele Roma-Ricerca Corrente #2020/1) Ricerca Corrente #2020/1
6 · The paper itself

Abstract

Darier disease (DD) is an autosomal dominant disorder due to pathogenic variants of the

Indexed as

cardiomyocyte disconnectionDarier diseasegene variantmolecular and cellular rehabilitationSERCA2

Identifiers

PMID38791022
PMCPMC11118942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.